Testing a Phone App with Guide Booklets for Adults with Sickle Cell Disease
Tests a phone app plus booklets giving sickle cell guidelines to adults with the disease.
Key facts
- Who runs it
- Ohio State University
- Where
- Chicago, Columbus, Nashville, and St Louis, United StatesSee the 4 sites
- Trial code
- Registry title
- Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- Status
- Recruiting
- People taking part
- 287 people, planned
- Started
- 13 Jan 2026
- Expected to end
- Mar 2032
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- mHealth app + booklets
- Record updated
- 23 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with sickle cell disease who have been treated at the sickle cell clinic for the past 12 months and can read and speak English.
- Age
- Older than 18 years
- Sex
- All sexes can join
- Disease stage
- Diagnosis of sickle cell disease (Hgb SS, SC or Sβ-thal)
- Earlier treatment
- Must have received care at the sickle cell disease clinic for the prior 12 months
Main reasons for not taking part
- Cannot speak and understand written English
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- receiving care at the SCD clinic for the prior 12 months,
- has a diagnosis of SCD (Hgb SS, SC, Sβ-thal),
- able to speak and understand written English,
- older than 18 years
- (1) to be involved in participants' clinical care
Where in United States
- University of Illinois at ChicagoChicago, United StatesContact: Saraf SantoshTaking people
- The Ohio State University Medical CenterColumbus, United StatesContact: Robert CroninTaking people
- Vanderbilt UniversityNashville, United StatesContact: Robert Cronin, MD, MSTaking people
- Washington University St. LouisSt Louis, United StatesContact: Allison KingTaking people
About the trial
What the trial wants to find out
In a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing SCD-specific guidelines through an mHealth application with booklets will decrease acute healthcare utilization and be cost-effective over booklets with the guidelines alone. Our team, head will test our hypotheses with the following aims: Aim 1: evaluate the effectiveness of the patient-facing guidelines mHealth app + booklet intervention to decrease acute healthcare utilization (hospitalizations, emergency room visits, and day hospital visits) in adults with SCD over the standard care in a randomized controlled trial, Aim 2: evaluate the implementation outcomes of the mHealth app + booklet using the capability, opportunity, and motivation-behavior (COM-B) and reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) frameworks, and Aim 3: evaluate the cost-effectiveness of patient-facing mHealth app + booklets vs. standard care in adults with SCD. is hybrid effectiveness-implementation trial design, according to the COM-B and RE-AIM frameworks with a mixed-methods approach, will give valuable insights into the effects, facilitators, and barriers to the implementation that will influence the effects of the patient-facing guidelines intervention.
The 2 groups in the trial
- mHealth app + bookletsExisting treatment, for comparison
A mHealth app that has patient facing guidelines and engaging content and a booklet with the guidelines that are made to be patient-facing.
- Standard careNo study treatment, for comparison
Group 1 will receive the control arm with standard care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease (PF-Guide)
- Plain-language title
- Testing a Phone App with Guide Booklets for Adults with Sickle Cell DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 23 March 2026